Observational studyRetina (Philadelphia, Pa.)2026
EFFICACY AND SAFETY OF AMNIOTIC MEMBRANE TRANSPLANTATION IN VITRECTOMY FOR EXTRA-LARGE OR LONG-STANDING MACULAR HOLES: A Prospective Clinical Study.
Observational study in Retina (Philadelphia, Pa.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
purposeTo evaluate the efficacy and safety of amniotic membrane transplantation during vitrectomy for extra-large or long-standing macular holes (MH).
methodsA single-center, noncomparative prospective observational study included eight eyes from eight patients with extra-large or long-standing MHs (six recurrent, two primary). All patients underwent vitrectomy with amniotic membrane transplantation over the MH. Baseline assessments included best-corrected visual acuity, optical coherence tomography, multifocal electroretinography, macula microperimetry, and adaptive optics imaging to evaluate photoreceptor cells on the graft surface. Outcome measures were recorded during follow-up.
resultsAll eight eyes achieved MH closure during the follow-up period, with 1 case developing amniotic membrane graft displacement that did not cause MH recurrence. After the follow-up ended, at 18 months postoperatively, this case experienced a recurrence of the MH due to rhegmatogenous retinal detachment(mean follow-up: 14.3 ± 8.1 months). Baseline MH diameter was 825.2 ± 265.9 µ m. Best-corrected visual acuity improved in four eyes (50%) and stabilized in others. Multifocal electroretinography showed increased amplitude and shortened peak time at 1 month postoperatively, peaking at 3 months and stabilizing by 6 months. Microperimetry revealed improved retinal sensitivity in five eyes (62.5%), with enhanced 2° and 4° fixation rates. Absolute scotomas resolved posttreatment. Adaptive optics imaging confirmed photoreceptor cell attachment on the graft surface. No adverse events related to the amniotic membrane were observed.
conclusionAmniotic membrane transplantation facilitates extra-large or long-standing MH closure, improves macular function, and demonstrates favorable safety. This approach may enhance photoreceptor recovery, supporting its clinical utility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.